Category: Flora Sam MD

June 2018: Flora Sam, MD

“A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction (CAPACITY HFpEF )” – Sponsor: Ironwood Pharmaceuticals, Inc.  PI: Flora Sam, MD; funded 2018-2019